{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:52:40Z","timestamp":1774619560550,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10067-021-05663-1","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T06:02:45Z","timestamp":1614924165000},"page":"3773-3781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of a lateral flow assay\u2013based IFN-\u03b3 release assay as a point-of-care test for the diagnosis of latent tuberculosis infection"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2926-2197","authenticated-orcid":false,"given":"Hoon Hee","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9404-0107","authenticated-orcid":false,"given":"Dong Hwan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6267-2046","authenticated-orcid":false,"given":"Jeong-Ran","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Gyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5949-248X","authenticated-orcid":false,"given":"Kyung-Wook","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6653-816X","authenticated-orcid":false,"given":"Tae Sun","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"5663_CR1","unstructured":"(2019) Global tuberculosis report 2019, Vol. 2020. Geneva: World Health Organization"},{"key":"5663_CR2","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMra1405427","volume":"372","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Chaisson RE, Raviglione M (2015) Latent Mycobacterium tuberculosis infection. N Engl J Med 372:2127\u20132135","journal-title":"N Engl J Med"},{"key":"5663_CR3","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben RM, Dodd PJ (2016) The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 13:e1002152","journal-title":"PLoS Med"},{"key":"5663_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","volume":"99","author":"GW Comstock","year":"1974","unstructured":"Comstock GW, Livesay VT, Woolpert SF (1974) The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 99:131\u2013138","journal-title":"Am J Epidemiol"},{"key":"5663_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/aje\/152.3.247","volume":"152","author":"E Vynnycky","year":"2000","unstructured":"Vynnycky E, Fine PE (2000) Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol 152:247\u2013263","journal-title":"Am J Epidemiol"},{"key":"5663_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.chest.2015.11.017","volume":"149","author":"JM Trauer","year":"2016","unstructured":"Trauer JM, Moyo N, Tay EL, Dale K, Ragonnet R, McBryde ES et al (2016) Risk of active tuberculosis in the five years following infection . . . 15%? Chest 149:516\u2013525","journal-title":"Chest"},{"key":"5663_CR7","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098\u20131104","journal-title":"N Engl J Med"},{"key":"5663_CR8","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/art.11137","volume":"48","author":"JJ Gomez-Reino","year":"2003","unstructured":"Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48:2122\u20132127","journal-title":"Arthritis Rheum"},{"key":"5663_CR9","first-page":"706","volume":"34","author":"SS Seong","year":"2007","unstructured":"Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, Kim TH, Jun JB, Yoo DH, Lee JT, Bae SC (2007) Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 34:706\u2013711","journal-title":"J Rheumatol"},{"key":"5663_CR10","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s10067-013-2387-z","volume":"33","author":"HW Kim","year":"2014","unstructured":"Kim HW, Park JK, Yang JA, Yoon YI, Lee EY, Song YW, Kim HR, Lee EB (2014) Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area. Clin Rheumatol 33:1307\u20131312","journal-title":"Clin Rheumatol"},{"key":"5663_CR11","unstructured":"(2020) WHO consolidated guideline on tuberculosis: tuberculosis preventive treatment, Vol. 2020. Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO"},{"key":"5663_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3899\/jrheum.140099","volume":"91","author":"D Goletti","year":"2014","unstructured":"Goletti D, Sanduzzi A, Delogu G (2014) Performance of the tuberculin skin test and interferon-gamma release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches. J Rheumatol Suppl 91:24\u201331","journal-title":"J Rheumatol Suppl"},{"key":"5663_CR13","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1001\/jama.286.14.1740","volume":"286","author":"GH Mazurek","year":"2001","unstructured":"Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, Iademarco MF, Rothel JS (2001) Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. Jama 286:1740\u20131747","journal-title":"Jama"},{"key":"5663_CR14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/thorax.57.9.804","volume":"57","author":"L Wang","year":"2002","unstructured":"Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM (2002) A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 57:804\u2013809","journal-title":"Thorax"},{"key":"5663_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","volume":"170","author":"T Mori","year":"2004","unstructured":"Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I (2004) Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 170:59\u201364","journal-title":"Am J Respir Crit Care Med"},{"key":"5663_CR16","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1001\/jama.293.22.2756","volume":"293","author":"YA Kang","year":"2005","unstructured":"Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ (2005) Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. Jama 293:2756\u20132761","journal-title":"Jama"},{"key":"5663_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","volume":"31","author":"A O\u2019Garra","year":"2013","unstructured":"O\u2019Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP (2013) The immune response in tuberculosis. Annu Rev Immunol 31:475\u2013527","journal-title":"Annu Rev Immunol"},{"key":"5663_CR18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1164\/rccm.201209-1621CI","volume":"188","author":"G Redelman-Sidi","year":"2013","unstructured":"Redelman-Sidi G, Sepkowitz KA (2013) IFN-gamma release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults. Am J Respir Crit Care Med 188:422\u2013431","journal-title":"Am J Respir Crit Care Med"},{"key":"5663_CR19","first-page":"28","volume":"11","author":"U Go","year":"2018","unstructured":"Go U, Park M, Kim U-N, Lee S, Han S, Lee J, Yang J, Kim J, Park S, Kim Y, Yoo H, Cha J, Park W, Kang H, Kim H, Park G, Kim M, Park O, Son H, Cho E, Na K, Kwon Y, Lee Y, Lee KH, Jeong E, Lee D, Yang BG, Jeon BY, Lee JK, Korea Tuberculosis Epidemic Investigation Service (2018) Tuberculosis prevention and care in Korea: evolution of policy and practice. J Clin Tuberc Mycobact Dis 11:28\u201336","journal-title":"J Clin Tuberc Mycobact Dis"},{"key":"5663_CR20","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","volume":"48","author":"L Barcellini","year":"2016","unstructured":"Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, Codecasa LR, Cugnata F, di Serio C, Ferrarese M, Goletti D, Lipman M, Rancoita PMV, Russo G, Tadolini M, Vanino E, Cirillo DM (2016) First evaluation of QuantiFERON-TB Gold Plus performance in contact screening. Eur Respir J 48:1411\u20131419","journal-title":"Eur Respir J"},{"key":"5663_CR21","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1128\/JCM.02498-16","volume":"55","author":"HW Moon","year":"2017","unstructured":"Moon HW, Gaur RL, Tien SS, Spangler M, Pai M, Banaei N (2017) Evaluation of QuantiFERON-TB Gold-Plus in health care workers in a low-incidence setting. J Clin Microbiol 55:1650\u20131657","journal-title":"J Clin Microbiol"},{"key":"5663_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tube.2017.11.014","volume":"108","author":"ED Pieterman","year":"2018","unstructured":"Pieterman ED, Liqui Lung FG, Verbon A, Bax HI, Ang CW, Berkhout J, Blaauw G, Brandenburg A, van Burgel ND, Claessen A, van Dijk K, Heron M, Hooghiemstra M, Leussenkamp-Hummelink R, van Lochem E, van Loo IHM, Mulder B, Ott A, Pontesilli O, Reuwer A, Rombouts P, Saegeman V, Scholing M, Vainio S, de Steenwinkel JEM (2018) A multicentre verification study of the QuantiFERON((R))-TB Gold Plus assay. Tuberculosis (Edinb) 108:136\u2013142","journal-title":"Tuberculosis (Edinb)"},{"key":"5663_CR23","first-page":"e00614","volume":"56","author":"ES Theel","year":"2018","unstructured":"Theel ES, Hilgart H, Breen-Lyles M, McCoy K, Flury R, Breeher LE et al (2018) Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon gamma release assays in patients at risk for tuberculosis and in health care workers. J Clin Microbiol 56:e00614\u2013e00618","journal-title":"J Clin Microbiol"},{"key":"5663_CR24","doi-asserted-by":"publisher","first-page":"e00985","DOI":"10.1128\/JCM.00985-19","volume":"57","author":"TK Venkatappa","year":"2019","unstructured":"Venkatappa TK, Punnoose R, Katz DJ, Higgins MP, Banaei N, Graviss EA et al (2019) Comparing QuantiFERON-TB Gold Plus with other tests to diagnose Mycobacterium tuberculosis infection. J Clin Microbiol 57:e00985\u2013e00919","journal-title":"J Clin Microbiol"},{"key":"5663_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3904\/kjim.2019.002","volume":"35","author":"SH Kim","year":"2020","unstructured":"Kim SH, Jo KW, Shim TS (2020) QuantiFERON-TB Gold PLUS versus QuantiFERON- TB Gold In-Tube test for diagnosing tuberculosis infection. Korean J Intern Med 35:383\u2013391","journal-title":"Korean J Intern Med"},{"key":"5663_CR26","doi-asserted-by":"publisher","first-page":"e01854","DOI":"10.1128\/JCM.01854-19","volume":"58","author":"D Won","year":"2020","unstructured":"Won D, Park JY, Kim HS, Park Y (2020) Comparative Results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus assays for detection of tuberculosis infection in clinical samples. J Clin Microbiol 58:e01854\u2013e01819","journal-title":"J Clin Microbiol"},{"key":"5663_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3349\/ymj.2019.60.4.375","volume":"60","author":"YG Hur","year":"2019","unstructured":"Hur YG, Hong JY, Choi DH, Kim A, Park SY, Kwon M, Kang K, Lee JM, Dockrell HM, Lee Y, Joo H, Cho SN (2019) A feasibility study for diagnosis of latent tuberculosis infection using an IGRA Point-of-Care Platform in South Korea. Yonsei Med J 60:375\u2013380","journal-title":"Yonsei Med J"},{"key":"5663_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"5663_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","volume":"187","author":"JZ Metcalfe","year":"2013","unstructured":"Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, Ha NP, Graviss EA (2013) Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med 187:206\u2013211","journal-title":"Am J Respir Crit Care Med"},{"key":"5663_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187313","volume":"12","author":"J Jonsson","year":"2017","unstructured":"Jonsson J, Westman A, Bruchfeld J, Stureg\u00e5rd E, Gaines H, Sch\u00f6n T (2017) A borderline range for Quantiferon Gold In-Tube results. PLoS One 12:e0187313","journal-title":"PLoS One"},{"key":"5663_CR31","unstructured":"(2020) Korean guidelines for tuberculosis, 4th ed, Vol. 2020. Cheongju: Korea Centers for Disease Control and Prevention"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05663-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05663-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05663-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T09:10:50Z","timestamp":1628673050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05663-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5663"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05663-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"20 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Asan Medical Center (IRB No.: 2017-1303). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}